4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-19-011646
Chief Business Officer bought 100 shares at $2.00 ($200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod Chief Business Officer | 2019-02-28 | Purchase | +100 | $2.00 | $200 | 7,300 | D |
| Open-market purchases · 100 sh · avg $2.00 · $200 | |||||||
Loading xslF345X03/tv515197_4.xml…